Literature DB >> 21470831

High prevalence of obsessive-compulsive disorder among posttraumatic stress disorder patients.

Nitsa Nacasch1, Leah Fostick, Joseph Zohar.   

Abstract

Posttraumatic obsessions have been reported in a few studies and case series. However, the magnitude of this phenomenon is still unknown. In the current study we systematically evaluated the prevalence of OCD in a sample of combat and terror related PTSD patients. Out of 44 referrals, 43% of the participants had PTSD with no OCD and 41% were diagnosed also with OCD. Six percent had sub-threshold OC symptoms. No difference was found between PTSD and PTSD-OCD participants' characteristics (including demographics, trauma-related factors, and other psychiatric co-morbidity). The surprisingly high number of OCD found in the current study suggests that PTSD-OCD might be underdiagnosed, signifies the importance of direct assessment of OCD in patients with PTSD, and raise questions regarding the underlying mechanism of post-traumatic OCD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21470831     DOI: 10.1016/j.euroneuro.2011.03.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  10 in total

1.  Lifetime Trauma Exposure and Posttraumatic Stress Disorder Among African Americans and Black Caribbeans by Sex and Ethnicity.

Authors:  Sophia Maria Gran-Ruaz; Robert Joseph Taylor; Grace Jacob; Monnica T Williams
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

Review 2.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

3.  The impact of lifetime PTSD on the seven-year course and clinical characteristics of OCD.

Authors:  Rachel Ojserkis; Christina L Boisseau; Madhavi K Reddy; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  Psychiatry Res       Date:  2017-09-19       Impact factor: 3.222

4.  A model of risk for perinatal posttraumatic stress symptoms.

Authors:  Rebecca Grekin; Michael W O'Hara; Rebecca L Brock
Journal:  Arch Womens Ment Health       Date:  2020-09-30       Impact factor: 3.633

5.  Trauma-related obsessive-compulsive disorder: a review.

Authors:  Kristy L Dykshoorn
Journal:  Health Psychol Behav Med       Date:  2014-04-23

6.  The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorder.

Authors:  T G Adams; B Kelmendi; C A Brake; P Gruner; C L Badour; C Pittenger
Journal:  Chronic Stress (Thousand Oaks)       Date:  2018-03-04

7.  Treatment of sexual trauma dissolves contamination fear: case report.

Authors:  Mirjam J Nijdam; Marthe M van der Pol; Ron E Dekens; Miranda Olff; Damiaan Denys
Journal:  Eur J Psychotraumatol       Date:  2013-01-07

8.  Obsessive-compulsive and posttraumatic stress symptoms among civilian survivors of war.

Authors:  Naser Morina; Vita Sulaj; Ulrich Schnyder; Richard Klaghofer; Julia Müller; Chantal Martin-Sölch; Michael Rufer
Journal:  BMC Psychiatry       Date:  2016-04-27       Impact factor: 3.630

Review 9.  First-line therapy for post-traumatic stress disorder: A systematic review of cognitive behavioural therapy and psychodynamic approaches.

Authors:  Emma Paintain; Simon Cassidy
Journal:  Couns Psychother Res       Date:  2018-07-03

10.  Understanding the overlap between OCD and trauma: development of the OCD trauma timeline interview (OTTI) for clinical settings.

Authors:  Lauren P Wadsworth; Nathaniel Van Kirk; Madeline August; J MacLaren Kelly; Felicia Jackson; Jennifer Nelson; Rose Luehrs
Journal:  Curr Psychol       Date:  2021-07-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.